Vaccination

Guidance and services

• Vaccination and immunisations
• COVID-19 vaccination programme
• COVID-19 spring booster 2024 (WHC/2024/009) (expired)
• COVID-19 spring booster 2023 (WHC/2023/04)
• Flu vaccination programme
• RSV vaccination programme
• Mpox (Monkeypox) vaccination programme
• Childhood routine vaccinations
• Older children and young adult vaccinations
• Vaccinations for students entering college or university
• Other routine vaccinations
• Travel vaccinations
• Additional selective immunisations and vaccines for individuals with underlying medical conditions
• HPV immunisation programme update (WHC/2023/016)
• Changes to shingles vaccinations (WHC/2023/024)
• National supplementary service: childhood influenza vaccination programme 2025 to 2026
• The national influenza immunisation programme 2024 to 2025 (WHC/2024/028)
• Vaccination and immunisation Welsh Health Circulars (WHC)
• The Primary Care (Contracted Services: Immunisations) Scheme Directions and Specification (COVID-19)
• COVID-19 vaccination of children aged 6 months to 4 years in a clinical risk group (WHC/2023/09) (expired)
• COVID-19 vaccine products (WHC/2023/33) (expired)
• National protocol for Comirnaty Omicron XBB 1.5 30micrograms/dose Covid-19 Vaccine
• National protocol for Comirnaty Omicron XBB 1.5 10micrograms/dose Covid-19 Vaccine (children aged 5 to 11 years)
• National protocol for Moderna (Spikevax) XBB.1.5 COVID-19 vaccine
• Eliminating hepatitis (B and C) as a public health threat: actions for 2022 to 2023 and 2023 to 2024 (WHC/2023/001)
• Infant pneumococcal conjugate vaccine (PCV) immunisation schedule: changes (WHC/2019/041)
• Influenza vaccines 2018 to 2021: guidance for health professionals
• National protocol for live attenuated influenza vaccine nasal spray suspension (LAIV)
• National protocol for inactivated influenza vaccine (IIV)
• Eligible groups in the 2025 to 2026 flu immunisation programme
• Children and adults who have outstanding routine immunisations: national supplementary service specification
• National protocol for COVID-19 mRNA vaccine in 5-year-old children to adults
• National protocol for COVID-19 mRNA vaccine in 5-year-old children to adults
• Mpox and gonorrhoea vaccination programme details: 2025
• Implementing changes to childhood vaccination schedules
• Selective neonatal Hepatitis B immunisation pathway (effective 1 July 2025)
• Routine childhood vaccination schedule (effective 1 July 2025)

Policy and background Includes strategy, reports, projects and assessments.

• National immunisation framework for Wales
  Policy and strategy
• Winter respiratory vaccination programme 2024 to 2025 (WHC/2024/033) (expired)
  Policy and strategy
• Introduction of RSV vaccination programme 2024 (WHC/2024/032)
  Policy and strategy
• The Primary Care (Contracted Services: Immunisations) (RSV) Directions 2024
  Legislation
• Vaccination of children to protect against measles (WHC/2024/008)
  Policy and strategy
• Vaccination of healthcare staff to protect against measles (WHC/2023/043)
  Policy and strategy
• The Directions to Local Health Boards as to the Statement of Financial Entitlements (Amendment) (No. 3) Directions 2023
  Legislation
• The Primary Medical Services (Influenza and Pneumococcal Immunisation Scheme) (Directed Enhanced Service) (Wales) (No. 2)
  Legislation
• COVID-19 spring vaccination programme 2025 (WHC/2024/047)
  Policy and strategy
• Update on RSV vaccination programme 2025 (WHC/2025/016)
  Policy and strategy
• Changes to routine childhood and selective neonatal hepatitis B vaccinations (WHC/2025/019)
  Policy and strategy
• Change to the influenza vaccination programme 2024 to 2025 (WHC/2024/046)
  Policy and strategy
• Pertussis vaccination for healthcare workers (WHC/2024/043)
  Policy and strategy
• RSV vaccination programme: children’s rights impact assessment
  Impact assessment
• The Primary Care (Contracted Services: Immunisations) (Influenza) Directions 2025
  Legislation
• Introduction of routine vaccinations for mpox and gonorrhoea (WHC/2025/021)
  Policy and strategy
• RSV vaccination programme: integrated impact assessment
  Impact assessment
• The national influenza immunisation programme 2025 to 2026 (WHC/2025/020)
  Policy and strategy
• The national COVID-19 vaccination programme autumn 2025 (WHC/2025/022)
  Policy and strategy
• Expansion of shingles immunisation for severely immunosuppressed people aged 18 to 49 (WHC/2025/028)
  Policy and strategy
• Introduction of a new RSV passive immunisation from autumn 2025 (WHC/2025/029)
  Policy and strategy
• Routine varicella (chickenpox) vaccination for young children from 1 January 2026 (WHC/2025/046)
  Policy and strategy